<qa>  What is the name of the study that will assess the safety, pharmacokinetics andThis randomized, double-blind study will assess the safety, pharmacokinetics and efficacy of a single and multiple doses of orally QD administered EDP-494 in healthy volunteers HV and in treatment-naive subjects with GT13 chronic hepatitis C CHC infection. 